JP2022540773A5 - - Google Patents
Info
- Publication number
- JP2022540773A5 JP2022540773A5 JP2021576889A JP2021576889A JP2022540773A5 JP 2022540773 A5 JP2022540773 A5 JP 2022540773A5 JP 2021576889 A JP2021576889 A JP 2021576889A JP 2021576889 A JP2021576889 A JP 2021576889A JP 2022540773 A5 JP2022540773 A5 JP 2022540773A5
- Authority
- JP
- Japan
- Prior art keywords
- dengue virus
- protein
- modified
- parent
- encoded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024227640A JP2025041836A (ja) | 2019-06-25 | 2024-12-24 | 弱毒化デングウイルス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962866477P | 2019-06-25 | 2019-06-25 | |
| US62/866,477 | 2019-06-25 | ||
| PCT/US2020/039166 WO2020263850A1 (en) | 2019-06-25 | 2020-06-23 | Attenuated dengue viruses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024227640A Division JP2025041836A (ja) | 2019-06-25 | 2024-12-24 | 弱毒化デングウイルス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022540773A JP2022540773A (ja) | 2022-09-20 |
| JP2022540773A5 true JP2022540773A5 (https=) | 2023-03-22 |
Family
ID=74060347
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576889A Pending JP2022540773A (ja) | 2019-06-25 | 2020-06-23 | 弱毒化デングウイルス |
| JP2024227640A Pending JP2025041836A (ja) | 2019-06-25 | 2024-12-24 | 弱毒化デングウイルス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024227640A Pending JP2025041836A (ja) | 2019-06-25 | 2024-12-24 | 弱毒化デングウイルス |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20220347285A1 (https=) |
| EP (2) | EP3990014A4 (https=) |
| JP (2) | JP2022540773A (https=) |
| CN (1) | CN114302738A (https=) |
| AU (1) | AU2020307532A1 (https=) |
| BR (1) | BR112021026201A8 (https=) |
| CA (1) | CA3145401A1 (https=) |
| CL (1) | CL2021003475A1 (https=) |
| CO (1) | CO2021017772A2 (https=) |
| CR (1) | CR20210677A (https=) |
| DO (1) | DOP2021000271A (https=) |
| IL (1) | IL289274A (https=) |
| MX (1) | MX2022000038A (https=) |
| PE (1) | PE20220296A1 (https=) |
| PH (1) | PH12021553305A1 (https=) |
| WO (1) | WO2020263850A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12178869B2 (en) | 2017-12-22 | 2024-12-31 | Codagenix Inc. | Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer |
| WO2019172982A1 (en) | 2018-03-08 | 2019-09-12 | Codagenix Inc. | Attenuated flaviviruses |
| CN119899808A (zh) * | 2024-12-05 | 2025-04-29 | 深圳湾实验室 | 登革减毒株及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2587084C (en) * | 2004-10-08 | 2019-07-16 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Modulation of replicative fitness by using less frequently used synonym ous codons |
| KR101621100B1 (ko) | 2007-03-30 | 2016-05-13 | 더 리서치 파운데이션 오브 스테이트 유니버시티 오브 뉴욕 | 백신에 유용한 약독화 바이러스 |
| US20120269849A1 (en) | 2009-10-09 | 2012-10-25 | Eckard Wimmer | Attenuated influenza viruses and vaccines |
| JP2016523251A (ja) * | 2013-06-21 | 2016-08-08 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | デングウイルスワクチン組成物およびその使用方法 |
| BR112017004452B1 (pt) * | 2014-09-05 | 2023-12-12 | The Research Foundation For The State University Of New York | Vírus atenuado, arbovírus atenuado, seus usos, composição de vacina, método de produção de um genoma de vírus atenuado, método de produção de um arbovírus atenuado e genoma de arbovírus atenuado |
| US11111481B2 (en) * | 2015-09-30 | 2021-09-07 | Ramot At Tel-Aviv University Ltd. | Attenuated virus mutated at sites of evolutionarily conserved RNA structure |
| CA3016697A1 (en) * | 2016-03-11 | 2017-09-14 | The Johns Hopkins University | Live attenuated zika virus vaccine |
| WO2019172982A1 (en) * | 2018-03-08 | 2019-09-12 | Codagenix Inc. | Attenuated flaviviruses |
-
2020
- 2020-06-23 CA CA3145401A patent/CA3145401A1/en active Pending
- 2020-06-23 CR CR20210677A patent/CR20210677A/es unknown
- 2020-06-23 AU AU2020307532A patent/AU2020307532A1/en active Pending
- 2020-06-23 US US17/621,125 patent/US20220347285A1/en active Pending
- 2020-06-23 MX MX2022000038A patent/MX2022000038A/es unknown
- 2020-06-23 BR BR112021026201A patent/BR112021026201A8/pt unknown
- 2020-06-23 EP EP20833206.4A patent/EP3990014A4/en active Pending
- 2020-06-23 PH PH1/2021/553305A patent/PH12021553305A1/en unknown
- 2020-06-23 CN CN202080060629.9A patent/CN114302738A/zh active Pending
- 2020-06-23 WO PCT/US2020/039166 patent/WO2020263850A1/en not_active Ceased
- 2020-06-23 JP JP2021576889A patent/JP2022540773A/ja active Pending
- 2020-06-23 PE PE2021002239A patent/PE20220296A1/es unknown
- 2020-06-23 EP EP26150104.3A patent/EP4707387A2/en active Pending
-
2021
- 2021-12-22 DO DO2021000271A patent/DOP2021000271A/es unknown
- 2021-12-22 IL IL289274A patent/IL289274A/en unknown
- 2021-12-24 CL CL2021003475A patent/CL2021003475A1/es unknown
- 2021-12-24 CO CONC2021/0017772A patent/CO2021017772A2/es unknown
-
2024
- 2024-12-24 JP JP2024227640A patent/JP2025041836A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022540773A5 (https=) | ||
| JP6743154B2 (ja) | Ｈｂｖを処置するための手段及び方法 | |
| TWI803521B (zh) | 免疫原性屈公病毒 | |
| Lázaro-Frías et al. | Distinct immunogenicity and efficacy of poxvirus-based vaccine candidates against Ebola virus expressing GP and VP40 proteins | |
| USRE41745E1 (en) | Recombinant Venezuelan Equine Encephalitis virus vaccine | |
| JP2021182922A5 (https=) | ||
| JP2016513115A5 (https=) | ||
| JP2009178165A (ja) | Ｈｉｖ調節／アクセサリータンパク質の融合タンパク質 | |
| JP2019151636A5 (https=) | ||
| JP2016539946A5 (https=) | ||
| RU2020132280A (ru) | Аттенуированные флавивирусы | |
| JP2004518631A5 (https=) | ||
| JP2018537996A (ja) | ネコカリシウイルスワクチン | |
| JP5675789B2 (ja) | 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型 | |
| RU2008102654A (ru) | Инактивированные химерные вакцины и связанные с ними способы применения | |
| JP2023522154A5 (https=) | ||
| WO2021207848A1 (en) | Mers-cov vaccine | |
| JP2001516583A5 (https=) | ||
| MX2026001148A (es) | Vacuna ibv con proteina de espicula dmv/1639 heterologa | |
| CN120202019A (zh) | 重组lsdv载体口蹄疫抗原构建体 | |
| Banic | Prevention of rabies by vitamin C | |
| JP2006101840A (ja) | 組み換えウイルスおよびその用途 | |
| US20160228531A1 (en) | Treatment of hepatitis d virus infections by redirection of t cells | |
| Lee et al. | Coronavirus disease 2019 (COVID-19) vaccine platforms: how novel platforms can prepare us for future pandemics: a narrative review | |
| NZ545954A (en) | DNA vaccine compositions and methods of use |